Sclavo Vaccines Association (SVA) is a non-profit research association based in Siena, Italy, focused on advancing vaccines and immunization strategies against infectious diseases. It promotes collaboration among academia, industry, and public health organizations to translate scientific findings into practical tools for disease prevention.
SVA’s work spans coordination of multi-partner R&D initiatives, scientific support for vaccine projects, and training and dissemination activities that strengthen immunization programs. The association engages across stages from early research through clinical evaluation and public health studies, with emphasis on respiratory and bacterial pathogens. Through European and international partnerships, it helps align research efforts with public health needs to improve access to effective vaccination.
The EU funds next-gen flu vaccines to enhance protection, speed up development, and improve pandemic readiness through pre-commercial procurement.
